SPONSOR

University of Chicago

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 2, Phase 1, Phase 4

Conditions studied: Prostate Cancer Total Knee Arthroplasty (TKA)Knee Osteoarthritis Knee Osteoarthritis (Knee OA)Knee Osteoarthritis (OA)Non-Small Cell Lung Cancer Metastatic Lung Cancer Paraesophageal Hernia Celiac Disease Pancreatic Adenocarcinoma

University of Chicago is a clinical research sponsor with 27 registered studies on ClinicalTrials.gov, of which 27 are actively recruiting participants. Research covers conditions including Prostate Cancer, Total Knee Arthroplasty (TKA), Knee Osteoarthritis, Knee Osteoarthritis (Knee OA).

The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Chicago

How many clinical trials has University of Chicago sponsored?

ClinicalMetric currently tracks 27 clinical trials sponsored by University of Chicago, of which 27 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Total Knee Arthroplasty (TKA), Knee Osteoarthritis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Chicago research focus on?

University of Chicago clinical trials span Prostate Cancer, Total Knee Arthroplasty (TKA), Knee Osteoarthritis, Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA), and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Chicago clinical trial?

To participate in a University of Chicago trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Chicago trials with current recruitment status updated daily.

University of Chicago

Frequently Asked Questions — University of Chicago

Clinical Trials by University of Chicago

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty

Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Posterior Rectus Sheath Hiatal Augmentation in Paraesophageal Hernia Repair

Tissue Destruction and Healing in Celiac Disease

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Prospective Assessments Following Immediate Lymphatic Reconstruction

Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Pain Control With Ketorolac and Nerve Block After Wrist and Hand Surgery

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Feasibility of a Dog Training Therapy Program in UC Outpatient Youth Receiving Psychiatric Services

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

Does Ethyl Chloride Spray Work?

Dysbiosis & Long COVID

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Olaparib in Patients With HRD Malignant Mesothelioma

Pathobiomes in Gut of Critically Ill Patients

A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy

Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery

Biobank Cardiac Surgery

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC